The Examination: New nicotine tablets spark concerns

    The latest product from the tobacco industry is a flavorful nicotine tablet that melts in your mouth.

    • Why it’s important: The products come in colorful packaging and flavors such as mint and berry. Unlike with pouches, there’s no wet sachet to discard, making them more appealing and discreet. Experts are concerned that tablets’ resemblance to mints or lozenges may make them appear harmless and more appealing to young people.

    The details:

    • In the U.K. and Switzerland, Philip Morris International recently introduced Zyn Melts, mint-flavored tablets that provide a nicotine hit as quickly as smoking a cigarette. Japan Tobacco International launched a similar product called Perlz in the U.K. in May. In the U.S., Nic Nac Naturals, a new nicotine company, has been selling flavored lozenges since 2022, now available in about 3,000 stores nationwide.
    • Tablets contain less nicotine than most pouches, with Zyn Melts and Perlz available in 1 and 2 mg doses and Nic Nac lozenges in 3 and 6 mg doses. The companies say they have child-resistant containers and do not market to kids.
    • What’s coming: Philip Morris has filed trademark protections for Zyn Melts in the U.S. and Europe, along with trademarks for “House of Zyn” and “Zyn Club,” signs that the company is positioning Zyn as a lifestyle brand. Nic Nac Naturals submitted a marketing authorization application to the Food and Drug Administration (FDA) in 2023 to sell its mint and fruit-flavored tablets in the U.S.

    The bigger picture:

    • Nicotine tablets have been available in the U.S. for years as smoking cessation aids, which require a special FDA approval as a pharmaceutical product. FDA would need to do a separate review in order to authorize sale to consumers.
    • But a new FDA rule allows nicotine products to be sold while their application is pending, meaning the products could be on shelves without any research on their appeal to adolescents.

    Read more: Vapes, pouches and now tablets: The tobacco industry’s newest nicotine product worries public health advocates